VGXI

In News

Conroe biotech company that owes taxpayers $248K has halted operations and failed to pay workers - Houston Chronicle

Houston Chronicle - Nov 21, 2025

Houston's cell and gene therapy factories on the rise, with more work to be done on R&D, report says - The Business Journals

The Business Journals - Feb 02, 2026

Conroe biotech company to repay over $248K from tax abatement - Houston Chronicle

Houston Chronicle - Nov 06, 2025

VGXI Completes Successful FDA Inspection Enabling Client BLA Approval Milestone, Advancing Its Leadership in Plasmid DNA Manufacturing - PR Newswire

PR Newswire - May 12, 2025

VGXI’s New Headquarters and Manufacturing Facility, Conroe, Texas - Pharmaceutical Technology

Pharmaceutical Technology - Jan 26, 2024

VGXI adds RNA suite to tap growing cell and gene therapy market - BioProcess International

BioProcess International - Mar 03, 2024

Manufacturing Best Project: VGXI - Engineering News-Record (ENR)

Engineering News-Record (ENR) - Dec 11, 2023

VGXI Headquarters and Biomanufacturing Facility Conroe - e-architect

e-architect - Aug 25, 2023

Conroe's Deison Technology Park is open for business, with vaccine company VGXI moved in - The Courier of Montgomery County

The Courier of Montgomery County - Oct 13, 2022

Inovio accuses manufacturing partner of hampering COVID-19 vaccine scale-up in lawsuit - Fierce Pharma

Fierce Pharma - Jun 05, 2020

GeneOne Life Science CEO's salary raise sparks outrage among investors - koreabiomed.com

koreabiomed.com - Jun 21, 2023

Conroe could turn part of failed tech park into Discovery Green - Houston Chronicle

Houston Chronicle - Jan 09, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment